2-120019100-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_020909.4(EPB41L5):​c.16C>T​(p.Arg6Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000482 in 1,451,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

EPB41L5
NM_020909.4 missense

Scores

8
10
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.58

Publications

0 publications found
Variant links:
Genes affected
EPB41L5 (HGNC:19819): (erythrocyte membrane protein band 4.1 like 5) Predicted to enable cytoskeletal protein binding activity and protein domain specific binding activity. Predicted to be involved in actomyosin structure organization. Predicted to act upstream of or within several processes, including chordate embryonic development; embryonic foregut morphogenesis; and mesoderm morphogenesis. Located in cytosol; nucleoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.788

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPB41L5NM_020909.4 linkc.16C>T p.Arg6Cys missense_variant Exon 2 of 25 ENST00000263713.10 NP_065960.2 Q9HCM4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPB41L5ENST00000263713.10 linkc.16C>T p.Arg6Cys missense_variant Exon 2 of 25 1 NM_020909.4 ENSP00000263713.5 Q9HCM4-1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD2 exomes
AF:
0.00000413
AC:
1
AN:
242034
AF XY:
0.00000761
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000902
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000482
AC:
7
AN:
1451686
Hom.:
0
Cov.:
31
AF XY:
0.00000692
AC XY:
5
AN XY:
722618
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32592
American (AMR)
AF:
0.00
AC:
0
AN:
41030
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25606
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39586
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85280
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53334
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5006
European-Non Finnish (NFE)
AF:
0.00000631
AC:
7
AN:
1109434
Other (OTH)
AF:
0.00
AC:
0
AN:
59818
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
EpiCase
AF:
0.0000546
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 22, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.16C>T (p.R6C) alteration is located in exon 2 (coding exon 1) of the EPB41L5 gene. This alteration results from a C to T substitution at nucleotide position 16, causing the arginine (R) at amino acid position 6 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.87
BayesDel_addAF
Pathogenic
0.26
D
BayesDel_noAF
Uncertain
0.13
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.53
D;.;.;.;.
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.95
D;D;.;D;D
M_CAP
Uncertain
0.26
D
MetaRNN
Pathogenic
0.79
D;D;D;D;D
MetaSVM
Uncertain
0.49
D
MutationAssessor
Uncertain
2.3
M;M;M;M;M
PhyloP100
4.6
PrimateAI
Pathogenic
0.84
D
PROVEAN
Pathogenic
-5.1
D;D;D;D;D
REVEL
Pathogenic
0.66
Sift
Pathogenic
0.0
D;D;D;D;D
Sift4G
Uncertain
0.0020
D;D;D;D;D
Polyphen
1.0
D;D;D;D;.
Vest4
0.84
MutPred
0.54
Loss of methylation at R6 (P = 0.0121);Loss of methylation at R6 (P = 0.0121);Loss of methylation at R6 (P = 0.0121);Loss of methylation at R6 (P = 0.0121);Loss of methylation at R6 (P = 0.0121);
MVP
0.85
MPC
0.55
ClinPred
1.0
D
GERP RS
4.3
PromoterAI
-0.076
Neutral
Varity_R
0.49
gMVP
0.57
Mutation Taster
=62/38
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1342040424; hg19: chr2-120776676; API